Frontlight ResearchEarly access
Trial site
Klaipeda University hospital
- 4running trials
- 7closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease3 trials
- Colorectal cancer2 trials
- Deep vein thrombosis and pulmonary embolism2 trials
- Atrial fibrillation1 trial
- Childhood cancers1 trial
- Prostate cancer1 trial
- Type 1 diabetes1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 24 trials
- Phase 34 trials
- Status
- Completed6 trials
- Active, not recruiting3 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Janssen Research & Development, LLC2 trials
- Regeneron Pharmaceuticals2 trials
- Bolt Medical1 trial
- Cryotherapeutics SA1 trial
- Eli Lilly and Company1 trial
- and 4 more
Running trials
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ulcerative colitis1 recruiting
Closed trials
Completed
Completed
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026